Trial · NCT06978192
Clinical Study on the Treatment of Herpes Zoster Pain With Dexmedetomidine Combined With Long-term High Voltage
NCT06978192, Phase 2, Recruiting, Fenghui Deng
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. Clinical Study on the Treatment of Herpes Zoster Pain With Dexmedetomidine Combined With Long-term High Voltage. Trials, record NCT06978192. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT06978192
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Clinical Study on the Treatment of Herpes Zoster Pain With Dexmedetomidine Combined With Long-term High Voltage
- NCT number
- NCT06978192
- Status
- Recruiting
- Phases
- Phase 2
- Enrollment
- 92 participants, estimated
- Lead sponsor
- Fenghui Deng
- Conditions
- Herpes Zoster (HZ)
- Interventions
- dexmedetomidine nasal spray group, long duration high voltage pulse RF therapy group
- First posted
- 2025-05-18
- Last updated
- 2025-05-18
Source ClinicalTrials.gov
Registered outcomes5
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Numerical Pain Rating Scale (NRS) | The patients were evaluated respectively before the operation, on the 7th day, the 30th day, the 90th day and the 180th day after the operation. | The pain degree of the patients was evaluated by using the Numerical Rating Scale for Pain (NRS). The NRS score was 0 when there was no pain. 1 to 3 points indicate mild pain. Points 4 to 6 indicate moderate pain. A score of 7 to 10 indicates severe pain. |
| Primary | The Hamilton Anxiety Scale (HAMA) | The scores were evaluated respectively before the operation, 7 days after the operation, 30 days after the operation, 90 days after the operation and 180 days after the operation. | uses a 5-point scoring system ranging from 0 to 4. A total score of ≥29 points may indicate severe anxiety. A score of 21 or above definitely indicates obvious anxiety. A score of 14 or above definitely indicates anxiety. A score above 7 May indicate anxiety. If it is less than 7 points, there will be no anxiety symptoms. |
| Secondary | Pittsburgh sleep quality index | The PSQI scores were recorded respectively before the operation, on the 7th day, 30th day, 90th day and 180th day after the operation. | The total PSQI score is between 0 and 20 points. The lower the score is, the better the sleep quality will be |
| Secondary | Interleukin 6 | Before the operation and the first day after the operation. | Interleukin-6 (IL-6) levels are positively correlated with the severity of postherpetic neuralgia (PHN) pain. |
| Secondary | blood pressure | Before, during and immediately after the operation | Measure blood pressure and record systolic and diastolic blood pressure respectively, with the unit being mmHg |
Source ClinicalTrials.gov
Outcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers0
The papers the trial lists on ClinicalTrials.gov.
None in this release.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT06978192
GET https://conductscience.org/api/trials/v1/NCT06978192/registered